Patient Perceptions of Care Coordination during Neoadjuvant Therapy for Gastrointestinal Cancers: A Mixed Methods Analysis
- PMID: 38351391
- PMCID: PMC11186897
- DOI: 10.1007/s12029-024-01030-w
Patient Perceptions of Care Coordination during Neoadjuvant Therapy for Gastrointestinal Cancers: A Mixed Methods Analysis
Abstract
Purpose: Effective cancer care coordination (CCC) is an integral component of health care delivery and critical to achieving optimal oncologic outcomes. Neoadjuvant therapy (NT), the delivery of multimodality therapy prior to surgery, is inherently complex and multidisciplinary, but CCC during NT is poorly understood. The objective of this study was to characterize patient perceptions of CCC during NT using a mixed methods approach.
Methods: This study is a cross-sectional analysis of patients with gastrointestinal cancers receiving NT who participated in a prospective longitudinal cohort study evaluating their real-time experience using a customized smartphone application. Patients completed the Cancer Care Coordination Questionnaire for Patients (CCCQ-P), a 20-item validated measure of care coordination quality, six weeks after initiating NT. Items were scored on a 5-point Likert scale, and subsections on communication (13 questions) and navigation (7 questions) were calculated with higher scores signifying better CCC. Univariate linear regression was used to calculate the impact of fragmented care and other factors on perceived CCC. Semi-structured interviews were conducted among a convenience sample of patients (n = 5); transcribed interviews were then coded using an inductive approach.
Results: Among 82 participants, mean age was 61 years old, 68% were male, and mean number of comorbidities was 1.68. Overall (mean 76.6 out of 100), communication subsection (48.6 out of 65), and navigation subsection (28.0 out of 35) CCCQ-P scores suggested overall positive perceptions of care coordination. Qualitative analysis of patient interviews highlighted the need for coordination among physicians before communicating the plan to patients as well as the importance of providers communicating plans in verbal and written form.
Conclusions: Successful completion of NT requires significant care coordination between patients and healthcare professionals. Yet, in this cross-sectional analysis of patients on a prospective cohort study, patient perceptions of CCC during NT were overall positive. Future research should focus on optimizing other aspects of care delivery in order to improve outcomes of NT.
Keywords: Cancer care coordination; Gastrointestinal cancer; Mixed-methods analysis; Neoadjuvant therapy.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Characterizing treatment burden during neoadjuvant therapy for patients with gastrointestinal cancer: A mixed methods analysis.J Surg Oncol. 2023 Aug;128(2):393-401. doi: 10.1002/jso.27288. Epub 2023 Apr 20. J Surg Oncol. 2023. PMID: 37079430
-
Quality of Life and Real-time Patient Experience During Neoadjuvant Therapy: A Prospective Cohort Study.Ann Surg. 2024 May 1;279(5):850-856. doi: 10.1097/SLA.0000000000006090. Epub 2023 Aug 29. Ann Surg. 2024. PMID: 37641957
-
The Association Between Patient-Reported Outcomes and Surgical Attrition During Neoadjuvant Therapy for Gastrointestinal Malignancies.J Gastrointest Cancer. 2024 Dec 11;56(1):31. doi: 10.1007/s12029-024-01153-0. J Gastrointest Cancer. 2024. PMID: 39661262
-
Patient experience and quality of life during neoadjuvant therapy for pancreatic cancer: a systematic review and study protocol.Support Care Cancer. 2021 Jun;29(6):3009-3016. doi: 10.1007/s00520-020-05813-2. Epub 2020 Oct 8. Support Care Cancer. 2021. PMID: 33030596
-
[Psychometric characteristics of questionnaires designed to assess the knowledge, perceptions and practices of health care professionals with regards to alcoholic patients].Encephale. 2004 Sep-Oct;30(5):437-46. doi: 10.1016/s0013-7006(04)95458-9. Encephale. 2004. PMID: 15627048 Review. French.
References
-
- Cloyd JM, Heh V, Pawlik TM, Ejaz A, Dillhoff M, Tsung A, Williams T, Abushahin L, Bridges JFP, Santry H. Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer: A Meta-Analysis of Randomized Controlled Trials. J Clin Med. 2020;9(4):1129. doi: 10.3390/jcm9041129. - DOI - PMC - PubMed
-
- Conroy T, Bosset JF, Etienne PL, et al. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22:702–715. doi: 10.1016/s1470-2045(21)00079-6. - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials